Search
Verona Pharma PLC
VRNAAdd to Watchlist
106.910USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
73.55BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
0.00%
Year to Date
0.00%
1 Year
+13.35%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
307.33P/E Dynamic
--Dividend TTM
0.27%Turnover Ratio
106.910Prev. Close
0.000Low
0.00Turnover
LossP/E Static
362.96P/B
0.00%Div Yield TTM
-16.50%ROA
106.93052wk High
1.22Volume Ratio
-135.74MNet Profit
687.93MShares
-0.0950EPS TTM
0.01Beta
-37.37%ROE
31.09052wk Low
0.11%Amplitude
95.45%Gross Margin
73.55BMarket Cap
0.16Reward/Risk
2.94%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Verona Pharma PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Verona Pharma PLC Info
Verona Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. It is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The Company's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The Company's wholly owned subsidiary is Verona Pharma, Inc.
Ticker SymbolVRNA
CompanyVerona Pharma PLC
CEODr. David S. Zaccardelli, Pharm.D.
Websitehttps://www.veronapharma.com/
Related Instruments
+0.50%
+1.28%
+0.83%
+6.26%
+1.27%
+1.42%
+2.11%
+0.90%
+6.27%
-0.54%
+3.36%
+1.30%
+0.14%
-1.38%
-0.73%
+0.41%
+2.98%
+0.40%
-1.09%Popular Instruments
73.025
-0.964 (-1.30%)
297.230
-0.780 (-0.26%)
208.780
-1.910 (-0.91%)
4119.130
-71.120 (-1.70%)
732.810
-13.420 (-1.80%)
2273.370
+88.620 (+4.06%)
1213.000
+79.010 (+6.97%)
349.710
-18.320 (-4.98%)
63414.700
-989.100 (-1.54%)
404.920
+4.430 (+1.11%)
FAQs
What is the current price of Verona Pharma PLC (VRNA)?
The current price of Verona Pharma PLC (VRNA) is 106.91.
What is the symbol of Verona Pharma PLC?
The ticker symbol of Verona Pharma PLC is VRNA.
What is the 52-week high of Verona Pharma PLC?
The 52-week high of Verona Pharma PLC is 106.93.
What is the 52-week low of Verona Pharma PLC?
The 52-week low of Verona Pharma PLC is 31.09.
What is the market capitalization of Verona Pharma PLC?
The market capitalization of Verona Pharma PLC is 73.55B.
What is the Earnings Per Share (EPS TTM) of Verona Pharma PLC (VRNA)?
The Earnings Per Share (EPS TTM) of Verona Pharma PLC (VRNA) is -2.13.
